查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1964054

細胞培養容器市場 - 全球產業規模、佔有率、趨勢、機會、預測：按類型、產品、最終用途、地區和競爭格局分類，2021-2031年

Cell Culture Vessels Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球細胞培養容器市場預計將從 2025 年的 49.5 億美元成長到 2031 年的 81.3 億美元，複合年成長率為 8.62%。

這些容器包括多孔孔盤、滾瓶、培養皿和燒瓶等專用無菌容器，旨在支持細胞在受控的體外環境中維持和增殖。市場成長趨勢主要受生物製藥產業的快速發展所驅動，特別是對單株抗體、疫苗和細胞療法等治療慢性疾病所需藥物的需求不斷成長。此外，藥物研發活動的活性化和嚴格的毒性測試要求也確保了對這些重要實驗室耗材的穩定需求。

市場概覽
預測期 2027-2031
市場規模：2025年 49.5億美元
市場規模：2031年 81.3億美元
複合年成長率：2026-2031年 8.62%
成長最快的細分市場 一次性的
最大的市場 北美洲

對科學技術創新的大量投資進一步推動了該領域的發展，並直接促進了培養容器的使用。根據歐洲製藥工業協會聯合會 (EFPIA) 的報告，預計到 2024 年，歐洲以研發為基礎的製藥業在研發方面的支出將達到約 550 億歐元。然而，儘管存在這些有利趨勢，市場在污染控制方面仍面臨重大挑戰。培養過程中持續存在的交叉污染威脅對生產者和研究人員來說都是一項重大挑戰，會導致代價高昂的批次失敗風險，並降低實驗數據的可靠性。

市場促進因素

全球對疫苗和生物製藥的需求激增是細胞培養容器市場的主要驅動力。隨著製藥公司專注於生產單株抗體和病毒載體，對可靠的無菌隔離系統（例如滾瓶和多孔孔盤）的需求不斷成長，從而促進了大規模的上游工程加工。這一生產趨勢在基礎設施的大規模資本投資中得到了明確的體現。例如，諾華公司在2025年4月的企業新聞稿中宣布，計劃在未來五年內投資230億美元，用於擴大其在美國的生產和研發設施。這種擴張也為耗材供應商帶來了經濟效益。康寧公司在2025年1月的財報中指出，其生命科學部門的年銷售額成長了8%，達到20億美元，這主要得益於生物製程需求的持續成長。

幹細胞和再生醫學行業的快速擴張，由於對專業培養環境的需求，進一步加速了市場成長。與傳統生物製藥不同，細胞和基因療法通常需要複雜的容器形狀，以確保自體或異體移植細胞培養過程中最佳的氣體交換和細胞黏附。該領域持續吸引大量資金，從而確保了高性能培養設備的穩定供應鏈。根據再生醫學聯盟在2024年10月舉行的「細胞與基因會議」（Cell & Gene Meeting on the Mesa）上發布的資料，僅2024年上半年，全球對該領域的投資就達到了109億美元，為臨床研發提供了資金支持。這直接轉化為對必需的一次性培養袋和培養瓶的需求成長。

市場挑戰

污染控制仍然是全球細胞培養容器市場的一大障礙，嚴重限制了企業的財務表現和營運效率。生物製藥生產過程中固有的交叉污染風險迫使製造商實施極為嚴格的檢驗和滅菌措施。這些必要但繁瑣的程序導致營運成本增加、生產前置作業時間延長，最終降低整體產量。此外，實際發生的污染事件可能導致災難性的批次失敗，需要丟棄高價值的生物製品，並嚴重延誤關鍵治療方法的上市進程。

從數據中可以看出，業界對降低這些風險的重視程度顯而易見。根據PDA 2024年的一項調查，超過80%的受訪製造商加強了驗證程序，以滿足日益嚴格的污染控制標準。這種將大量資源投入無菌保證和合規性的舉措，使得原本用於創新和產能擴張的資金減少。因此，持續存在的污染威脅不僅損害了產品的完整性，也為擴充性和市場准入設置了高壁壘，直接阻礙了產業的成長。

市場趨勢

隨著生物製藥企業將操作一致性和高通量篩檢置於優先地位，自動化容器的設計研發正在加速。為了實現與機器人移板機和液體處理系統的無縫整合，容器設計正朝著標準化的微孔盤形狀發展。這造就了堅固耐用、與機械手相容的結構，從而消除了人工操作帶來的許多不確定性。這種向標準化、自動化耗材的產業趨勢也反映在主要供應商的財務表現上。例如，賽多利斯斯泰迪生技公司（Sartorius Stedim Biotech）在2025年1月發布的2024會計年度中期財務報告中指出，其銷售額達27.8億歐元，耗材業務也顯著復甦，這得益於客戶調整庫存水準以支援自動化生物製程活動。

同時，用於3D細胞培養的專用容器的出現，透過提供比傳統單層培養更接近生理環境的培養條件，正在改變藥物研發的工作流程。研究人員擴大採用先進的支架、微流體晶片和超低黏附培養板，這些設備旨在促進類器官和球狀體的生長，從而在療效和毒性測試中提供更優的預測數據。對這些先進培養平台的需求顯著推動了主要企業持續的收入成長。正如賽默飛世爾科技公司在2025年1月發布的《2024會計年度第四季及全年報告》中所述，該公司累計全年銷售額將達到428.8億美元，這反映出該行業對創新生物科學技術和實驗室產品在推動複雜生物學研究方面的持續依賴。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球細胞培養容器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（可重複使用、一次性）
    • 依產品類型（袋子、保溫瓶、盤子、瓶子、其他）
    • 透過申請（製藥和生物技術公司、學術和研究機構、合約生產組織和合約研究組織）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美細胞培養容器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲細胞培養容器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區細胞培養容器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲細胞培養容器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美細胞培養容器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球細胞培養容器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • STEMCELL Technologies Canada Inc.
  • Greiner Bio-One International GmbH
  • Corning Incorporated
  • Wilson Wolf Manufacturing, LLC
  • Danaher Corporation
  • WR International, LLC.
  • Sartorius AG
  • Cell Culture Company, LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25385

The Global Cell Culture Vessels Market is projected to expand from USD 4.95 Billion in 2025 to USD 8.13 Billion by 2031, reflecting a CAGR of 8.62%. These vessels, which comprise specialized sterile containers such as multi-well plates, roller bottles, petri dishes, and flasks, are engineered to support cell maintenance and growth within controlled in vitro settings. The market's upward trajectory is primarily driven by the rapid growth of the biopharmaceutical sector, particularly the increasing demand for monoclonal antibodies, vaccines, and cell-based therapies needed to combat chronic diseases. Additionally, the intensification of drug discovery initiatives and stringent toxicity testing requirements ensures a consistent demand for these essential laboratory consumables.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.95 Billion
Market Size 2031USD 8.13 Billion
CAGR 2026-20318.62%
Fastest Growing SegmentSingle-use
Largest MarketNorth America

Substantial financial commitment to scientific innovation further underpins this sector, directly fueling the usage of culture vessels. As reported by EFPIA, the research-based pharmaceutical industry in Europe allocated an estimated €55,000 million toward R&D in 2024. However, despite these favorable trends, the market confronts a significant obstacle regarding contamination control; the persistent threat of cross-contamination during culture processes poses a risk of expensive batch failures and compromised experimental data, representing a critical challenge for both manufacturers and researchers.

Market Driver

The escalating global demand for vaccines and biopharmaceuticals acts as a primary catalyst for the cell culture vessels market. As pharmaceutical developers focus on producing monoclonal antibodies and viral vectors, there is an intensified need for reliable, sterile containment systems like roller bottles and multi-well plates to facilitate large-scale upstream processing. This manufacturing momentum is highlighted by significant capital allocation toward infrastructure; for example, Novartis announced in an April 2025 corporate press release a plan to invest $23 billion over five years to broaden its U.S. manufacturing and R&D footprint. Such expansion translates into financial gains for consumable suppliers, with Corning Incorporated reporting in their January 2025 financial results that Life Sciences sales rose 8% to $2.0 billion for the year, largely due to sustained bioprocessing demand.

The rapid expansion of the stem cell and regenerative medicine industries further accelerates market growth by necessitating specialized cultivation environments. Unlike traditional biologics, cell and gene therapies often require advanced vessel geometries to ensure optimal gas exchange and cell adherence during the cultivation of autologous or allogeneic batches. This sector continues to attract significant funding, ensuring a steady procurement channel for high-performance culture apparatus. According to the Alliance for Regenerative Medicine's presentation at the 'Cell & Gene Meeting on the Mesa' in October 2024, global sector investments reached $10.9 billion in the first half of 2024 alone, funding clinical advancements that directly translate into increased volume requirements for critical single-use bags and flasks.

Market Challenge

Contamination control remains a formidable impediment to the Global Cell Culture Vessels Market, significantly constraining financial performance and operational efficiency. The inherent risk of cross-contamination during sensitive biopharmaceutical production forces manufacturers to implement extremely rigorous validation and sterilization measures. These necessary but burdensome protocols increase operational costs and extend production lead times, thereby reducing overall throughput. Furthermore, actual contamination events result in catastrophic batch failures, necessitating the disposal of high-value biologic products and causing severe delays in bringing critical therapies to market.

The industry's intense focus on mitigating these risks is quantitatively evident. According to the Parenteral Drug Association (PDA) in 2024, over 80% of surveyed manufacturers upgraded their validation protocols to meet tightening contamination control standards. This substantial allocation of resources toward sterility assurance and compliance diverts capital from innovation and capacity expansion. Consequently, the persistent threat of contamination not only jeopardizes product integrity but also creates high barriers to scalability and market entry, directly hampering the sector's growth trajectory.

Market Trends

The development of automation-compatible vessel designs is accelerating as biopharmaceutical manufacturers prioritize operational consistency and high-throughput screening. To integrate seamlessly with robotic plate movers and liquid handlers, vessel engineering is shifting toward standardized microplate footprints featuring rigid, gripper-friendly structures that eliminate the variability associated with manual manipulation. This industrial push for standardized, automation-ready consumables is reflected in the financial performance of major suppliers; for instance, Sartorius Stedim Biotech reported in its January 2025 preliminary results for fiscal 2024 that it generated sales revenue of €2,780 million, noting a distinct revitalization in its consumables business as customers normalized inventory levels to support automated bioprocessing activities.

Simultaneously, the emergence of specialized vessels for three-dimensional cell culture is transforming drug discovery workflows by providing environments that are more physiologically relevant than traditional monolayers. Researchers are increasingly procuring advanced scaffolds, microfluidic chips, and ultra-low attachment plates designed to facilitate the growth of organoids and spheroids, which offer superior predictive data for efficacy and toxicity testing. This demand for sophisticated culture platforms contributes significantly to the recurring revenue streams of life sciences leaders. As noted in Thermo Fisher Scientific's 'Fourth Quarter and Full Year 2024 Financial Results' released in January 2025, the company reported full-year revenue of $42.88 billion, reflecting the industry's sustained reliance on its innovative bioscience capabilities and laboratory products to advance complex biological research.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • STEMCELL Technologies Canada Inc.
  • Greiner Bio-One International GmbH
  • Corning Incorporated
  • Wilson Wolf Manufacturing, LLC
  • Danaher Corporation
  • WR International, LLC.
  • Sartorius AG
  • Cell Culture Company, LLC

Report Scope

In this report, the Global Cell Culture Vessels Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Culture Vessels Market, By Type

  • Reusable
  • Single use

Cell Culture Vessels Market, By Product

  • Bags
  • Flasks
  • Plates
  • Bottles
  • Others

Cell Culture Vessels Market, By End Use

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CMOs & CROs

Cell Culture Vessels Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Culture Vessels Market.

Available Customizations:

Global Cell Culture Vessels Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Culture Vessels Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Reusable, Single use)
    • 5.2.2. By Product (Bags, Flasks, Plates, Bottles, Others)
    • 5.2.3. By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CMOs & CROs)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Cell Culture Vessels Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Product
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Culture Vessels Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Cell Culture Vessels Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Cell Culture Vessels Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End Use

7. Europe Cell Culture Vessels Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Product
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell Culture Vessels Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Cell Culture Vessels Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Cell Culture Vessels Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Cell Culture Vessels Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Cell Culture Vessels Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End Use

8. Asia Pacific Cell Culture Vessels Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Culture Vessels Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Cell Culture Vessels Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Cell Culture Vessels Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Cell Culture Vessels Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Cell Culture Vessels Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Cell Culture Vessels Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Product
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cell Culture Vessels Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Cell Culture Vessels Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Cell Culture Vessels Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End Use

10. South America Cell Culture Vessels Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Product
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Culture Vessels Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Cell Culture Vessels Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Cell Culture Vessels Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cell Culture Vessels Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck KGaA
  • 15.3. STEMCELL Technologies Canada Inc.
  • 15.4. Greiner Bio-One International GmbH
  • 15.5. Corning Incorporated
  • 15.6. Wilson Wolf Manufacturing, LLC
  • 15.7. Danaher Corporation
  • 15.8. WR International, LLC.
  • 15.9. Sartorius AG
  • 15.10. Cell Culture Company, LLC

16. Strategic Recommendations

17. About Us & Disclaimer